Strategic targeting of macrophages can effectively inhibit the pro-tumour effects of TAMs while simultaneously promoting the cross-presentation of CD8+T cells and amplifying their anti-tumour effects [40], indicating that macrophages have potential as prognostic biomarkers and therapeutic targets. Here, CD8A is linked to neoplasm.